Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hiromi Kawasumi"'
Autor:
Kentaro Masuhiro, Genju Koh, So Takata, Shingo Nasu, Hiromune Takada, Satomu Morita, Ayako Tanaka, Takayuki Shiroyama, Naoko Morishita, Hidekazu Suzuki, Norio Okamoto, Hiromi Kawasumi, Chihiro Konishi, Tomonori Hirashima
Publikováno v:
Respiratory Medicine Case Reports, Vol 28, Iss , Pp - (2019)
The present report describes the case of a 64-year-old woman with advanced lung adenocarcinoma expressing mutant epidermal growth factor receptor (EGFR). The patient developed follicular lymphoma during treatment with the EGFR-tyrosine kinase inhibit
Externí odkaz:
https://doaj.org/article/c0a5d2b999a24225b7bc53d9bc9e5f5b
Autor:
Akane Matsusita, Naoko Morishita, Ayako Tanaka, Hiromi Kawasumi, Hiroko Yoshida, Tomohiro Kanai, Shingo Nasu, Kunimitsu Kawahara, Tomonori Hirashima, Hidekazu Suzuki, Yoshitaka Tamura, Norio Okamoto
Publikováno v:
Anticancer Research. 40:6971-6978
Background/aim We retrospectively investigated the significance of pre-treatment interferon-gamma release (IGR) as a biomarker for predicting the efficacy of immune checkpoint inhibitor treatment (ICI-tx). Patients and methods This study included non
Autor:
Shoji Hashimoto, Ayako Tanaka, Norio Okamoto, Akane Matsushita, Hiromi Kawasumi, Hiroko Yoshida, Tomohiro Kanai, Kunimitsu Kawahara, Hidekazu Suzuki, Naoko Morishita, Toshio Tanaka, Yoshimi Noda, Yumiko Samejima, Shingo Nasu, Tomonori Hirashima, Yoshitaka Tamura
Publikováno v:
Anticancer Research. 40:2787-2793
Background/aim We aimed to study the association between the quantitative interferon-gamma (IFN-γ) levels and clinical outcomes in non-small-cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors (ICIs). Patients and methods Sample
Autor:
Norio Okamoto, Yumiko Samejima, Shingo Nasu, Yoshimi Noda, Shoji Hashimoto, Ayako Tanaka, Hiromi Kawasumi, Hiroko Yoshida, Hidekazu Suzuki, Yoshitaka Tamura, Toshio Tanaka, Kunimitsu Kawahara, Tomohiro Kanai, Naoko Morishita, Tomonori Hirashima, Akane Matsushita
Publikováno v:
Anticancer Research. 39:6231-6240
BACKGROUND/AIM The present study aimed to prospectively examine the usefulness of interferon-gamma (IFN-γ) release (IGR) as a biomarker in non-small-cell lung cancer patients receiving immune checkpoint inhibitor treatment (ICI-Tx). PATIENTS AND MET
Autor:
Genju Koh, Hiromune Takada, Takayuki Shiroyama, Kentaro Masuhiro, Chihiro Konishi, Norio Okamoto, Hiromi Kawasumi, Satomu Morita, Ayako Tanaka, Tomonori Hirashima, So Takata, Hidekazu Suzuki, Naoko Morishita, Shingo Nasu
Publikováno v:
Respiratory Medicine Case Reports, Vol 28, Iss, Pp-(2019)
Respiratory Medicine Case Reports
Respiratory Medicine Case Reports
The present report describes the case of a 64-year-old woman with advanced lung adenocarcinoma expressing mutant epidermal growth factor receptor (EGFR). The patient developed follicular lymphoma during treatment with the EGFR-tyrosine kinase inhibit
Autor:
Toshi Miyagawa, Izuo Tsuyuguchi, Yasukazu Ohmoto, Hiroshi Fujiwara, Chisato Ueta, Hiromi Kawasumi, Susumu Kishimoto, Hiroshi Kida
Publikováno v:
European Journal of Immunology. 26:3066-3073
gammadelta T cell populations are known to expand in response to intracellular bacterial infectious agents regardless of previous priming. We have shown previously that soluble factor(s) produced by Mycobacterium-stimulated monocytes activate cord bl
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 56(4)
More than 1 asbestos body (AB) per ml of bronchoalveolar lavage fluid (BALF) under light microscopy was defined as AB positive (ABP) and suggests an occupational asbestos exposure. We microscopically evaluated the AB number per one ml of BALF, which